My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2019/1686 of 8 October 2019 authorising the extension of use of bovine milk basic whey protein isolate as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

Commission Implementing Regulation (EU) 2019/1686 of 8 October 2019 authorising the extension of use of bovine milk basic whey protein isolate as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

Implementing Regulation (EU) 2019/1686 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

1.   The entry in the Union list of authorised novel foods, established under Implementing Regulation (EU) 2017/2470, referring to the substance bovine milk basic whey protein isolate shall be amended as specified in the Annex to this Regulation. 2.   The entry in the Union list referred to in paragraph 1 shall include the conditions of use and labelling requirements laid down in the Annex to this Regulation. 3.   The authorisation provided for in this Article shall be without prejudice to the provisions of Regulation (EU) No 609/2013 and of Directive 2002/46/EC.

Article 2

Open ↗

The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows: (1) In Table 1 (Authorised novel foods), the entry on ‘Bovine milk basic whey protein isolate’ is replaced by the following: ‘ Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements Data Protection Bovine milk basic whey protein isolate Specified food category Maximum levels The designation of the novel food on the labelling of the foodstuffs containing it shall be “Milk whey protein isolate”. Food supplements containing bovine milk basic whey protein isolate shall bear the following statement: “This food supplement should not be consumed by infants/children/adolescents under the age of one/three/eighteen (*) years” (*) Depending on the age group the food supplement is intended for.   Authorised on 20 November 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Armor Protéines S.A.S., 19 bis, rue de la Libération 35460 Saint-Brice-en- Coglès, France. During the period of data protection the novel food bovine milk basic whey protein isolate is authorised for placing on the market within the Union only by Armor Protéines S.A.S. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Armor Protéines S.A.S. End date of the data protection: 20 November 2023.’ Infant formulae as defined in Regulation (EU) No 609/2013 Follow-on formulae as defined in Regulation (EU) No 609/2013 Total diet replacement foods for weight control as defined by Regulation (EU) No 609/2013 Foods for special medical purposes as defined in Regulation (EU) No 609/2013 Food Supplements as defined in Directive 2002/46/EC 30 mg/100 g (powder) 3,9 mg/100 mL (reconstituted) 30 mg/100 g (powder) 4,2 mg/100 mL (reconstituted) 300 mg/day 30 mg/100 g (powder formula for infants during the first months of life until the introduction of appropriate complementary feeding) 3,9 mg/100 mL (reconstituted formula for infants during the first months of life until the introduction of appropriate complementary feeding) 30 mg/100 g (powder formula for infants when appropriate complementary feeding is introduced) 4,2 mg/100 mL (reconstituted formula for infants when appropriate complementary feeding is introduced) 58 mg/day for young children 380 mg/day for children and adolescents from 3 to 18 years of age 610 mg/day for adults 25 mg/day for infants 58 mg/day for young children 250 mg/day for children and adolescents from 3 to 18 years of age 610 mg/day for adults (2) in Table 2 (Specifications), the entry on ‘Bovine milk basic whey protein isolate’ is replaced by the following: ‘ Authorised Novel Food Specification Bovine milk basic whey protein isolate Description Bovine milk basic whey protein isolate is a yellowish grey powder obtained from bovine skimmed milk via a series of isolation and purification steps. Characteristics/Composition Total protein (w/weight of product): ≥ 90 % Lactoferrin (w/weight of product): 25-75 % Lactoperoxidase (w/weight of product): 10-40 % Other proteins (w/weight of product): ≤ 30 % TGF-β2: 12-18 mg/100 g Moisture: ≤ 6,0 % pH (5 % solution w/v): 5,5 – 7,6 Lactose: ≤ 3,0 % Fat: ≤ 4,5 % Ash: ≤ 3,5 % Iron: ≤ 25 mg/100 g Heavy Metals Lead: < 0,1 mg/kg Cadmium: < 0,2 mg/kg Mercury: < 0,6 mg/kg Arsenic: < 0,1 mg/kg Microbiological criteria: Aerobic mesophilic count: ≤ 10 000 CFU/g Enterobacteriaceae : ≤ 10 CFU/g Escherichia coli : Negative/g Coagulase positive Staphylococci: Negative/g Salmonella : Negative/25 g Listeria : Negative/25 g Cronobacter spp.: Negative/25 g Moulds: ≤ 50 CFU/g Yeasts: ≤ 50 CFU/g CFU: Colony Forming Units’

Other acts of the same type
Commission Implementing Regulation (EU) 2017/2011 of 9 November 2017 amending Regulation (EC) No 951/2007 laying down implementing rules for cross-border cooperation programmes financed under Regulation (EC) No 1638/2006 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2017/2015 of 9 November 2017 laying down technical information for the calculation of technical provisions and basic own funds for reporting with reference dates from 30 September 2017 until 30 December 2017 in accordance with Directive 2009/138/EC of the European Parliament and of the Council on the taking-up and pursuit of the business of Insurance and Reinsurance (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2001 of 8 November 2017 approving propan-1-ol as an existing active substance for use in biocidal products of product-type 1, 2 and 4 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2002 of 8 November 2017 approving L(+) lactic acid as an existing active substance for use in biocidal products of product-types 2, 3 and 4 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2003 of 8 November 2017 approving fludioxonil as an active substance for use in biocidal products of product-types 7, 9 and 10 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2004 of 8 November 2017 approving 2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products of product-type 12 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2005 of 8 November 2017 approving margosa extract, cold-pressed oil of Azadirachta indica seeds without shells extracted with super-critical carbon dioxide as an existing active substance for use in biocidal products of product-type 19 (Text with EEA relevance. )Commission Implementing Regulation (EU) 2017/2006 of 8 November 2017 amending Council Regulation (EU) 2016/44 concerning restrictive measures in view of the situation in LibyaCommission Implementing Regulation (EU) 2017/1997 of 7 November 2017 amending Implementing Regulations (EU) 2016/184 and (EU) 2016/185 extending the definitive countervailing and anti-dumping duty on imports of crystalline silicon photovoltaic modules and key components (i.e. cells) originating in or consigned from the People's Republic of China to imports of crystalline silicon photovoltaic modules and key components (i.e. cells) consigned from Malaysia and Taiwan, whether declared as originating in Malaysia and in Taiwan or notCommission Implementing Regulation (EU) 2017/2009 of 7 November 2017 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (‘Quartirolo Lombardo’ (PDO))Commission Implementing Regulation (EU) 2017/2156 of 7 November 2017 entering a name in the register of protected designations of origin and protected geographical indications (‘Kiełbasa piaszczańska’ (PGI))Commission Implementing Regulation (EU) 2017/1992 of 6 November 2017 entering a name in the register of protected designations of origin and protected geographical indications (‘Slavonski kulen’/‘Slavonski kulin’ (PGI))

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next